Based on the data evidenced in the group non-diabetic, in which the circulating IL-10 levels were positively correlated with IL-6 and IFN-γ, at baseline, as well as with TNF-α after the treatment ends, we can suggest that a regulatory status was maintained even with the presence of periodontitis. This evidence concerns the gene IL6 and periodontitis.